Paperonium

← Back to the plain-language case

Abstract reports reduced PKN1 and PKN4, but the Results report increased PKN2 and no PKN4

Nat Commun (2018) · doi:10.1038/s41467-018-04411-5 · PMC5998138

Summary

For the isogenic cell-line comparison, the abstract states that PCQ "was used to identify reduced levels of serine/threonine protein kinases PKN1 and PKN4 in CFBE41o- cells compared to HBE41o- cells". The Results and Fig. 7 instead describe a PKN1/PKN2/PKN3 cluster in which PKN2 was "three-fold more abundant in CFBE41o- cells" and confirmed by western blot, the evidence for PKN1 is "conflicting" even about its presence, and PKN4 is never mentioned outside the abstract. The paper's own data files agree with the Results: PKN2-specific peptides have a CFBE41o-/HBE41o- ratio of 3.000, the only peptide on the PKN1 node is shared with PKN2 and PKN3 (ratio 0.500), and no file contains PKN4. Because the abstract is the indexed summary and this sentence is one of its two biological examples, it gets both the proteins and the direction of the one validated kinase change wrong.

What the paper reports

Abstract:

PCQ was used to identify reduced levels of serine/threonine protein kinases PKN1 and PKN4 in CFBE41o- cells compared to HBE41o- cells and to elucidate that shorter proteoforms of full-length caspase-4 and ephrin B receptor are differentially expressed.

Results, "Analysis of individual protein clusters", paragraph 2. This paragraph is the only passage in the Results about the PKN proteins:

Finally, a serine/threonine-protein kinase (PKN) cluster comprising PKN1 (Q16512), PKN2 (Q16513), and PKN3 (Q6P5Z2) was identified. PKN2 (PRK2) shares 59% sequence identity with PKN1 and was three-fold more abundant in CFBE41o- cells (Fig. 7b). Western blot confirmed that PKN2 was more abundant in CFBE41o- cells when normalized to the expression levels of Na+/K+-ATPase (Fig. 7c and 7d, Supplementary Fig. 12).

A difference in PKN2 protein quantity may contribute to the altered cell morphology between HBE41o- and CFBE41o– cells in cell culture because bronchial epithelial airway cells require PKN2 to establish apical junctions32.

PKN1 is part of two incomplete protein pairs with either PKN2 or PKN3, which provide conflicting evidence for a potential presence of PKN1. While the incomplete protein pair with PKN2 shows discrepant ratio values for the peptide nodes (∆ ≥ 2-fold), the incomplete protein pair with PKN3 shows similar ratio values (∆ < 2-fold).

Fig. 7 legend, panels b and d:

b The protein cluster of serine–threonine kinase-related protein kinases PKN1, PKN2, and PKN3 is displayed.

d Western blot analysis was used to verify the difference in PKN2 expression levels between HBE41o– and CFBE41o– cells.

Data in the western blot represent independent biological replicates, CFBE41o–: n = 2, HBE41o–: n = 2

Results, "Comparison of two isogenic cell lines with PCQ", on the labelling, which fixes the direction of the ratios:

CFBE41o– and HBE41o– cells were labeled with light and heavy isobaric isotopologues, respectively, and analyzed in a single experiment (n = 1)

Methods, "Cell culture and western blot". The only antibody against a PKN protein is anti-PKN2:

PKN2 and NaK-ATPase were detected by incubation with monoclonal anti-PKN2 antibody

Discussion. The summary of the cell-line comparison mentions no kinase:

When comparing two isogenic cell lines, we found that caspase-4 and ephrin type B receptor protein fragments were differentially regulated relative to their longer proteoforms, respectively.

What the paper's own numbers show

Method. I counted every mention of PKN1 to PKN4 in the PMC-archived text, separately for the abstract and for the rest of the article (Results, Discussion, Methods, figure legends). I searched every body sentence that names a PKN protein for wording of reduction ("reduc", "decreas", "lower", "less abundant", "down"). I then opened the two supplementary data files that hold the cell-line quantification. Supplementary Data 7 (MOESM9, the 180 classified complete protein pairs) gives log2 ratios for unique and shared peptide nodes. Supplementary Data 6 (MOESM8, "Network 5" in the Results) is the XGMML peptide-to-protein network for CFBE41o- vs HBE41o-, with ion counts for each peptide node. From it I extracted the connected component that holds the three PKN accessions. I converted log2 ratios to ratios. I checked the ratio direction against the normalized light and heavy ion counts, since the Results say light = CFBE41o- and heavy = HBE41o-. I also queried UniProt for a human gene named PKN4. Every number below is printed by recompute.py.txt.

Quantity Location Reported Recomputed from the paper's own text and data
Kinases named as changed in the cell-line comparison Abstract PKN1 and PKN4, "reduced levels" in CFBE41o- Results name PKN2 as changed (increased); no reduction of any PKN protein is stated
Mentions of PKN1 / PKN2 / PKN3 / PKN4 Abstract vs rest of article 1 / 0 / 0 / 1 in the abstract 5 / 13 / 4 / 0 in the rest of the article
Body sentences naming a PKN protein that use reduction wording Results, Methods, legends — 0 of 11
Members of the PKN cluster Results; Fig. 7b legend PKN1 (Q16512), PKN2 (Q16513), PKN3 (Q6P5Z2) same three in Supplementary Data 6; no PKN4 node in the network file
PKN2-specific peptides (3 peptides), CFBE41o-/HBE41o- Results ("three-fold more abundant in CFBE41o- cells"); Supp. Data 7 log2 1.58496 ratio 3.000 (= 2^1.585; normalized light/heavy ions 4.5/1.5 in Supp. Data 6), an increase
PKN2 western blot Results; Fig. 7d (n = 2 vs n = 2); Supp. Fig. 12 "more abundant in CFBE41o- cells" an increase, the same direction as the mass-spectrometry ratio
PKN3-specific peptides (3 peptides) Supp. Data 7 only log2 −0.678 ratio 0.625 (1.60-fold lower; light/heavy 2.5/4.0); not discussed in the text
Shared peptide IADFGLCK (PKN1, PKN2, PKN3) Supp. Data 6, 7 log2 −1.000 ratio 0.500 (light/heavy 0.75/1.5)
Peptides mapped to the PKN1 node Supp. Data 6 — only the shared IADFGLCK. The node groups Q16512 with two fragment entries (H0Y429, K7EL10), and its gene-name field reads "PKN1,PKN2"
PKN1–PKN2 incomplete pair Results ("∆ ≥ 2-fold") — unique 3.000 vs shared 0.500, a 6.00-fold discrepancy
PKN1–PKN3 incomplete pair Results ("∆ < 2-fold") — unique 0.625 vs shared 0.500, a 1.25-fold discrepancy
A PKN1-specific or PKN4 ratio article and all supplementary files — none exists
Human gene named PKN4 UniProt (query 2026-10-23) — none; human PKN genes are PKN1, PKN2 (alias PRK2, PRKCL2) and PKN3

The body's account is internally consistent, and it reproduces from the data files: both the "∆ ≥ 2-fold" and the "∆ < 2-fold" statements match the network ratios. The abstract sentence is the outlier. It names a protein (PKN4) with no data behind it in the paper. It describes as an identified reduction a PKN1 inference that the body calls conflicting. It leaves out the one PKN change that was quantified with protein-specific peptides and checked by western blot, which is an increase.

Figure

The abstract's kinase sentence and what the rest of the paper reports, side by side

Figure 1. Short verbatim excerpts from the abstract (left, orange) and from the Results and Fig. 7 legend (right, blue), with the supplementary-data values printed by recompute.py.txt. The abstract names PKN1 and PKN4 and says "reduced". The body names a PKN1/PKN2/PKN3 cluster and reports PKN2 three-fold more abundant in CFBE41o- cells (ratio 3.0 in Supplementary Data 6 and 7), confirmed by western blot. It calls the evidence for PKN1's presence conflicting, and its only peptide is shared with PKN2 and PKN3 (ratio 0.5). PKN4 is mentioned nowhere outside the abstract.

Each PKN protein on one ratio axis: the abstract's claimed direction against the paper's own ratios

Figure 2. CFBE41o-/HBE41o- abundance ratios on one log2 axis; the vertical line marks no change (ratio 1). The orange hatched bands mark the abstract's claim for PKN1 and PKN4. The abstract gives a direction ("reduced") and no value, so the bands span the whole "reduced" side and carry no magnitude. Filled blue circles are ratios from protein-specific peptides in Supplementary Data 6 and 7: PKN2 at 3.0, which is the Results' "three-fold more abundant", and PKN3 at 0.625, which the text does not discuss. The hollow blue circle is the PKN1 node's only peptide, which is shared with PKN2 and PKN3 (0.5), so it is not specific to PKN1. PKN4 has no data point because the paper and its supplements contain none.

Why it matters

Explanations considered

Status

Suggested correction

  1. Revise the abstract sentence so it matches the Results. For example: "PCQ was used to identify increased levels of the serine/threonine protein kinase PKN2 in CFBE41o- cells compared to HBE41o- cells, confirmed by western blot, and to elucidate that shorter proteoforms of full-length caspase-4 and ephrin B receptor are differentially expressed."
  2. If a statement about PKN1 is kept, word it as the body does: the evidence for a PKN1 proteoform is inconclusive and rests on a peptide it shares with PKN2 and PKN3.
  3. Remove "PKN4". If another protein was meant, name it and give the supporting data.